Fig. 2From: Effect of bevacizumab combined with chemotherapy on SDF-1 and CXCR4 in epithelial ovarian cancer and its prognosisComparison of quality of life between group A and group B after intervention. The scores of physical health (A), mental health (B), material life (C), and social function (D) in group B were significantly higher than those in group A (P<0.001)Back to article page